CRISPR patent ruling has little impact in laboratory setting, MIT researchers say – The Tech
|
CRISPR patent ruling has little impact in laboratory setting, MIT researchers say
The Tech Researchers at MIT maintained that the U.S. Patent Trial and Appeal Board's Feb. 15 decision, which affirmed the Broad Institute's patent claims on using CRISPR-Cas9 technology to edit eukaryotic genomes, had little impact on future laboratory research. |
